Pharmaceutical News

RSS

Study identifies factors that increase antibiotic use among travelers

Travelers carrying standby antibiotics take them more often than those traveling without such drugs. Having antibiotics packed in the bags allows their use - against recommendations - also for mild and moderate diarrhea, i.e. cases not requiring medication.

13 Jun 2018

Researchers explore how postoperative patients can be protected from opioid addiction

Greater coordination is needed between surgeons and physicians about the prescription of pain-relieving opioid drugs following surgery to help identify patients who are at risk of becoming opioid addicts.

13 Jun 2018

Study shows prevalence of medications with potential to cause depression among U.S. adults

A new study from University of Illinois at Chicago researchers suggests that more than one-third of U.S. adults may be using prescription medications that have the potential to cause depression or increase the risk of suicide, and that because these medications are common and often have nothing to do with depression, patients and health care providers may be unaware of the risk.

12 Jun 2018

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

Midgut neuroendocrine tumors are a rare type of cancer that develops in the small intestine and colon. Roughly 12,000 people are diagnosed with this disease each year. In January, the United Stated Food and Drug Administration approved Lutathera, a first-of-its-kind peptide receptor radionuclide therapy.

12 Jun 2018

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase in influenza vaccines.

12 Jun 2018

Multiple barriers may stop high-risk individuals from accessing HIV drug

Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

12 Jun 2018

Researchers identify new form of depression

In a new study, researchers from Hiroshima University have identified a new form of depression that could be used to inform a new generation of treatments.

11 Jun 2018

Sustained preoperative opioid use predicts continued use following surgical procedure

Patients who take prescription opioids for a longer period before spinal surgery are more likely to continue using opioids several months after surgery, reports a study in the June 6, 2018, issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

8 Jun 2018

Researchers discover new therapy combination that may help treat ovarian cancer

Researchers at The University of Kansas Cancer Center have discovered a therapy combination that may be helpful in the treatment of certain types of ovarian cancer.

8 Jun 2018

Brits cautioned against taking certain medicines abroad

The UK's Foreign Office has issued a statement warning Brits against carrying certain medications with them on holidays abroad.

7 Jun 2018

Research project aims to study opioid prescriptions after cesarean delivery and hysterectomy

Each year, approximately 1.8 million women will have a cesarean delivery or hysterectomy. While opioids are the mainstay treatment for acute pain after these surgeries, most women use only a fraction of the opioids prescribed and do not properly dispose of unused drugs

7 Jun 2018

Researchers develop model that predicts changes in BUP exposure during pregnancy

Buprenorphine (BUP) is approved for the treatment of opioid addiction. The current dosing regimen of BUP in pregnant women is based on recommendations designed for non-pregnant adults, but physiological changes during pregnancy may alter BUP exposure and efficacy.

7 Jun 2018

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.

From Yokogawa Fluence Analytics 7 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Two-drug combination provides more reliable, effective care for women suffering miscarriage

A combination of the drugs mifepristone and misoprostol can help bring closure to some women and their families suffering from miscarriage, and reduces the need for surgical intervention to complete the painful miscarriage process.

7 Jun 2018

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

A class of immunotherapy drugs called checkpoint inhibitors has shown great promise against cancer in some patients.

7 Jun 2018

FDA files complaint against company marketing unapproved hand sanitizers

The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.

7 Jun 2018

Relying on arthritis therapies alone may not improve patients' mental health, shows study

Drugs used to treat rheumatoid arthritis may impact mental health by improving pain and stiffness and by targeting inflammatory processes common to arthritis and depression; however, a recent review of published studies demonstrates that relying on rheumatoid arthritis therapies alone may not meaningfully improve patients' mental health.

6 Jun 2018

Price check on drug ads: Would revealing costs help patients control spending?

President Donald Trump wants to control spending on drugs. One of his big ideas: include prices in advertisements, just like warnings about side effects.

6 Jun 2018

FDA warns nine online networks to stop illegal marketing of unapproved opioids

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

6 Jun 2018

Pharmaceutical News

Study identifies factors that increase antibiotic use among travelers

Researchers explore how postoperative patients can be protected from opioid addiction

Study shows prevalence of medications with potential to cause depression among U.S. adults

New FDA-approved therapy provides better quality of life for patients with midgut neuroendocrine tumors

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

Multiple barriers may stop high-risk individuals from accessing HIV drug

Researchers identify new form of depression

Sustained preoperative opioid use predicts continued use following surgical procedure

Researchers discover new therapy combination that may help treat ovarian cancer

Brits cautioned against taking certain medicines abroad

Research project aims to study opioid prescriptions after cesarean delivery and hysterectomy

Researchers develop model that predicts changes in BUP exposure during pregnancy

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

Two-drug combination provides more reliable, effective care for women suffering miscarriage

Researchers’ attempt to combine immunotherapy drugs have turned out to be failure

FDA files complaint against company marketing unapproved hand sanitizers

Relying on arthritis therapies alone may not improve patients' mental health, shows study

Price check on drug ads: Would revealing costs help patients control spending?

FDA warns nine online networks to stop illegal marketing of unapproved opioids

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News